INDUSTRYVECTORTRAIN - EUROPEAN LABCOURSE: ADVANCED METHODS FOR INDUSTRIAL PRODUCTION, PURIFICATION AND CHARACTERISATION OF GENE VECTORS (Life sciences, genomics and biotechnology for health) (2004-01-01 - 2005-09-30) (»add to infobox)

To allow gene & cell therapies to evolve more quickly into biomedical sciences, it is necessary to train the scientific community on: i the basic knowledge of the biology of vectors and stem cells, ii the expertise of their production, purification and characterisation, iii the assessment of their efficiency and bio-safety, iv the definition of regulations where they can be transformed into new medicines commercially exploitable. Their evolution is today still far from its objective, since the insufficient knowledge of their biology, a scarce co-ordination of research projects and the absence of integration of activities of the actors operating in different areas (research, industry, health products regulation and marketing). Therefore, the realisation of a multidisciplinary training programme, which integrates various scientific and technological approaches is necessary to address a real need of the community. This proposal concerns a theoretical and practical course, where 32 selected young researchers will be trained on the advanced processes of vector production, purification and quality control. The course is expected to gather young scientists from industrial and academic institutions, coming from several EU and candidate countries. It will present training and scientific innovations: for the first time the various aspects of the development of vector technology from the bench to the industrial level will be provided to the community. Theoretical modules will be open to large public including industries and regulatory agencies, and the status of the art will be presented and discussed. The course will a) allow young researchers from industries and academia to acquire hands on experience on vectors development and awareness of ethical, legal and socio-economical implications; b) implement an environment where all concerned institutions will work on process to develop new therapeutic tools. Keywords: gene vectors, industrial development, training, technology transfer

COORDINATOR (1/1)

PARTICIPANTS (1/1)

RELATED THEMATIC AREAS (1/1)